Summary: S.3105 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for S.3105. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (06/21/2018)

Pharmaceutical Origin Transparency Act of 2018

This bill amends the Federal Food, Drug, and Cosmetic Act to require a drug manufacturer to publish information about each country in which its drugs are manufactured. (A drug is manufactured in a country if the active pharmaceutical ingredient is manufactured in such country.)